Bakul Pharma Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 1997.
1997 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Bakul Pharma Private Limited

Bakul Pharma Private Limited, a active private limited company, was established on 06 October 1997 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24230MH1997PTC111089. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.99 M.

It upholds a compliant status. Employing 92 professional, Its leadership includes Madhavi Yogin Majmudar (Director), Yogin Ranjit Majmudar (Director). Past directors included Davinder Marwah Singh, Anand Vadilal Mehta. It holds ₹13.50 Cr open charges and ₹33.08 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 16/2 Sterling Centre4Th Floor Dr A B Road Worli, Mumbai, Maharashtra, 400018.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MH1997PTC111089

  • Registration Number

    111089

  • Incorporation Date

    06 October 1997

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.99 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.99 M
  • Company Age 28 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 13.50 Cr
  • Satisfied Charges ₹ 33.08 Cr
  • Revenue Growth **** -0.80%
  • Profit Growth **** 76.13%
  • Ebitda **** 89.95%
  • Net Worth 23.54%
  • Total Assets -4.28%
Company report

Bakul Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Bakul Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Bakul Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Madhavi Yogin Majmudar Director 16 Jan 1998 Current
Yogin Ranjit Majmudar Director 06 Oct 1997 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 30 Aug 2007 Past
Pramod Abcsdd Director 01 Oct 2009 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Bakul Pharma.

Bakul Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.8% decrease. The company also saw a substantial improvement in profitability, with a 76.13% increase in profit. The company's net worth Soared by an impressive increase of 23.54%.

Bakul Pharma revenue growth over time
Bakul Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -0.80%
*******
*******
*******
*******
Revenue from Operations
*******
 -0.78%
*******
*******
*******
*******
Total Assets
*******
 -4.28%
*******
*******
*******
*******
Profit or Loss
*******
 76.13%
*******
*******
*******
*******
Net Worth
*******
 23.54%
*******
*******
*******
*******
EBITDA
*******
 89.95%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Bakul Pharma?

In 2023, Bakul Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹135,000,000.00

Satisfied Charges

₹330,800,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 12.00 Cr
  • The Hongkong And Shanghai Banking Corporation Limited : 1.50 Cr
Latest Charge Details
Date Lender Amount Status
20 Oct 2021 Hdfc Bank Limited ₹5.50 Cr Open
29 Nov 2019 The Hongkong And Shanghai Banking Corporation Limited ₹1.50 Cr Open
12 Sep 2019 Hdfc Bank Limited ₹6.50 Cr Open
27 Feb 2019 The Hongkong And Shanghai Banking Corporation Limited ₹6.00 Cr Satisfied
19 Jul 2018 The Hongkong And Shanghai Banking Corporation Limited ₹1.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Bakul Pharma?

Bakul Pharma has a workforce of 92 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Bakul Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bakul Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Bakul Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Bakul Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Bakul Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Charges

    Progress on A charge with Hdfc Bank Limited of Rs. 55.00 M registered on 20 Oct 2021 with Charge ID 100495954 was modified on 06 Mar 2023. was documented.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 55.00 M with Charge ID 100495954 was registered on 20 Oct 2021. was documented.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 65.00 M registered on 12 Sep 2019 with Charge ID 100289541 was modified on 24 Jun 2021. was recorded as a recent event.

  • Charges

    The activity A charge registered on 27 Feb 2019 via Charge ID 100251125 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 13 Dec 2019. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Bakul Pharma Private Limited?

The CIN of Bakul Pharma Private Limited is U24230MH1997PTC111089.

Where is Bakul Pharma Private Limited headquartered?

Bakul Pharma Private Limited is headquartered at 16/2 Sterling Centre4Th Floor Dr A B Road Worli, Mumbai, Maharashtra, 400018.

When was Bakul Pharma Private Limited incorporated?

Bakul Pharma Private Limited was incorporated on 06 October 1997.

Who are the current directors of Bakul Pharma Private Limited?

The current directors of Bakul Pharma Private Limited are

What is the primary industry of Bakul Pharma Private Limited?

The primary industry of Bakul Pharma Private Limited is Manufacturing.

Is Bakul Pharma Private Limited a listed company?

Bakul Pharma Private Limited is unlisted.

What is the capital structure of Bakul Pharma Private Limited?

The authorized capital of Bakul Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.99 M.

What is the compliance status of Bakul Pharma Private Limited?

The compliance status of Bakul Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available